Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Guardant Health, Inc.GH · Entity 3238 | Chief Information Officer | October 01, 2026 | October 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Guardant Health, Inc.
Report date October 01, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 42,773 |
Ending reported balance
After 2026-10-01 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2026-10-01 · Exercise / conversion · Acquired 1,607 · Balance 41,401 Row 2 · 2026-10-01 · Exercise / conversion · Acquired 1,084 · Balance 42,485 Row 3 · 2026-10-01 · Exercise / conversion · Acquired 1,995 · Balance 44,480 Row 4 · 2026-10-01 · Exercise / conversion · Acquired 1,360 · Balance 45,840 Row 5 · 2026-10-01 · Tax withholding · Disposed 3,067 · Balance 42,773 F1: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-10-01 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-10-01 · Exercise / conversion · Disposed 1,607 · Balance 0 F2: This represents a restricted stock unit award granted on November 7, 2022 that vested over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vested in equal quarterly installments over the remaining three-year period thereafter. F3: Not applicable for Restricted Stock Units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-10-01 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-10-01 · Exercise / conversion · Disposed 1,084 · Balance 0 F4: This represents a restricted stock unit award granted on December 13, 2023 that vested over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vested in equal quarterly installments over the remaining two-year period thereafter. F3: Not applicable for Restricted Stock Units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 7,978 |
Reported balance
After 2026-10-01 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-10-01 · Exercise / conversion · Disposed 1,995 · Balance 7,978 F5: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3: Not applicable for Restricted Stock Units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 8,162 |
Reported balance
After 2026-10-01 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-10-01 · Exercise / conversion · Disposed 1,360 · Balance 8,162 F6: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3: Not applicable for Restricted Stock Units. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2: This represents a restricted stock unit award granted on November 7, 2022 that vested over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vested in equal quarterly installments over the remaining three-year period thereafter.
F3: Not applicable for Restricted Stock Units.
F4: This represents a restricted stock unit award granted on December 13, 2023 that vested over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vested in equal quarterly installments over the remaining two-year period thereafter.
F5: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
F6: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 04, 2026 Filed Mar 5, 2026 22:44 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 10,000 | $28.61 | $286,100.00 |
DisclosureSEC source: 0001927831-26-000004 · wk-form4_1772750655.xml · nonDerivative · entry 6 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,643 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 22:44 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 10,000 | $28.37 | $283,700.00 |
DisclosureSEC source: 0001927831-26-000004 · wk-form4_1772750655.xml · nonDerivative · entry 5 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,643 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 22:44 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 5,000 | $32.86 | $164,300.00 |
DisclosureSEC source: 0001927831-26-000004 · wk-form4_1772750655.xml · nonDerivative · entry 4 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,643 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 22:44 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,000 | $74.00 | $74,000.00 |
DisclosureSEC source: 0001927831-26-000004 · wk-form4_1772750655.xml · nonDerivative · entry 3 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,643 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 22:44 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 15,000 | $47.20 | $708,000.00 |
DisclosureSEC source: 0001927831-26-000004 · wk-form4_1772750655.xml · nonDerivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,643 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 22:44 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 2,119 | $47.20 | $100,016.80 |
DisclosureSEC source: 0001927831-26-000004 · wk-form4_1772750655.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,643 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 01, 2026 Filed Jan 5, 2026 23:00 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,995 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001927831-26-000002 · wk-form4_1767654008.xml · derivative · entry 12 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,961 Underlying: Common Stock · 1,995 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| January 01, 2026 Filed Jan 5, 2026 23:00 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionPerformance-Based Restricted Stock Units · Derivative | 3,696 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001927831-26-000002 · wk-form4_1767654008.xml · derivative · entry 11 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,698 Underlying: Common Stock · 3,696 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This represents a performance-based restricted stock unit award granted on February 26, 2024, that a performance metric was achieved and that 33% of the shares subject to such award vested on March 1, 2025. 33% of the shares subject to the award vested on January 1, 2026, and the remaining 34% of the shares subject to the award will vest on January 1, 2027. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| January 01, 2026 Filed Jan 5, 2026 23:00 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,083 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001927831-26-000002 · wk-form4_1767654008.xml · derivative · entry 10 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,252 Underlying: Common Stock · 1,083 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| January 01, 2026 Filed Jan 5, 2026 23:00 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionPerformance-Based Restricted Stock Units · Derivative | 12,856 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001927831-26-000002 · wk-form4_1767654008.xml · derivative · entry 9 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,856 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This represents a performance-based restricted stock unit award granted on June 7, 2023, with a performance metric and 2-year vest period that was achieved. The shares vested on January 1, 2026. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| January 01, 2026 Filed Jan 5, 2026 23:00 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,607 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001927831-26-000002 · wk-form4_1767654008.xml · derivative · entry 7 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,821 Underlying: Common Stock · 1,607 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| January 01, 2026 Filed Jan 5, 2026 23:00 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 9,392 | $102.14 | $959,298.88 |
DisclosureSEC source: 0001927831-26-000002 · wk-form4_1767654008.xml · nonDerivative · entry 6 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,524 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| January 01, 2026 Filed Jan 5, 2026 23:00 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,995 | $0.00 | $0.00 |
DisclosureSEC source: 0001927831-26-000002 · wk-form4_1767654008.xml · nonDerivative · entry 5 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,916 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 01, 2026 Filed Jan 5, 2026 23:00 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 3,696 | $0.00 | $0.00 |
DisclosureSEC source: 0001927831-26-000002 · wk-form4_1767654008.xml · nonDerivative · entry 4 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,921 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 01, 2026 Filed Jan 5, 2026 23:00 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,083 | $0.00 | $0.00 |
DisclosureSEC source: 0001927831-26-000002 · wk-form4_1767654008.xml · nonDerivative · entry 3 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,225 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 01, 2026 Filed Jan 5, 2026 23:00 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 12,856 | $0.00 | $0.00 |
DisclosureSEC source: 0001927831-26-000002 · wk-form4_1767654008.xml · nonDerivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,142 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 01, 2026 Filed Jan 5, 2026 23:00 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,607 | $0.00 | $0.00 |
DisclosureSEC source: 0001927831-26-000002 · wk-form4_1767654008.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,286 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2025 Filed Dec 18, 2025 00:20 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 637 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001927831-25-000012 · wk-form4_1766017217.xml · derivative · entry 3 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,275 Underlying: Common Stock · 637 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on June 15, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| December 15, 2025 Filed Dec 18, 2025 00:20 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 323 | $102.67 | $33,162.41 |
DisclosureSEC source: 0001927831-25-000012 · wk-form4_1766017217.xml · nonDerivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,679 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| December 15, 2025 Filed Dec 18, 2025 00:20 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 637 | $0.00 | $0.00 |
DisclosureSEC source: 0001927831-25-000012 · wk-form4_1766017217.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,002 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 08, 2025 Filed Dec 11, 2025 02:32 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 2,000 | $104.60 | $209,204.20 |
DisclosureSEC source: 0001927831-25-000010 · wk-form4_1765420366.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,365 F1 · price: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $104.58 to $104.75. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 00:05 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 7,858 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001927831-25-000008 · wk-form4_1759449929.xml · derivative · entry 7 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,956 Underlying: Common Stock · 7,858 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 00:05 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,084 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001927831-25-000008 · wk-form4_1759449929.xml · derivative · entry 6 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,335 Underlying: Common Stock · 1,084 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 00:05 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,607 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001927831-25-000008 · wk-form4_1759449929.xml · derivative · entry 5 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,428 Underlying: Common Stock · 1,607 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 00:05 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 5,348 | $62.65 | $335,052.20 |
DisclosureSEC source: 0001927831-25-000008 · wk-form4_1759449929.xml · nonDerivative · entry 4 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,365 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 00:05 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 7,858 | $0.00 | $0.00 |
DisclosureSEC source: 0001927831-25-000008 · wk-form4_1759449929.xml · nonDerivative · entry 3 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,713 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 00:05 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,084 | $0.00 | $0.00 |
DisclosureSEC source: 0001927831-25-000008 · wk-form4_1759449929.xml · nonDerivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,855 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 00:05 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,607 | $0.00 | $0.00 |
DisclosureSEC source: 0001927831-25-000008 · wk-form4_1759449929.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,771 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2025 Filed Sep 17, 2025 21:15 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 638 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001927831-25-000006 · wk-form4_1758143748.xml · derivative · entry 3 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,912 Underlying: Common Stock · 638 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on June 15, 2024. The remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| September 15, 2025 Filed Sep 17, 2025 21:15 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 324 | $54.79 | $17,751.96 |
DisclosureSEC source: 0001927831-25-000006 · wk-form4_1758143748.xml · nonDerivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,164 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| September 15, 2025 Filed Sep 17, 2025 21:15 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 638 | $0.00 | $0.00 |
DisclosureSEC source: 0001927831-25-000006 · wk-form4_1758143748.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,488 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 22:46 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 711 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001927831-25-000004 · wk-form4_1756939584.xml · derivative · entry 3 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 711 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock unit award was granted on November 2, 2021, and vested 25% of the shares subject to such award on September 1, 2022. The remaining 75% of the shares subject to such award vests in equal installments on each quarterly anniversary of September 1, 2022 during the three-year period thereafter. F1 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 22:46 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 361 | $67.42 | $24,338.62 |
DisclosureSEC source: 0001927831-25-000004 · wk-form4_1756939584.xml · nonDerivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,850 F1 · shares: Not applicable for Restricted Stock Units. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 22:46 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 711 | $0.00 | $0.00 |
DisclosureSEC source: 0001927831-25-000004 · wk-form4_1756939584.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,211 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 21, 2025 Filed Aug 22, 2025 20:58 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 2,000 | $61.76 | $123,510.00 |
DisclosureSEC source: 0001576280-25-000264 · wk-form4_1755896302.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,500 Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 01:25 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,084 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000223 · wk-form4_1751505919.xml · derivative · entry 5 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,419 Underlying: Common Stock · 1,084 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 01:25 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,607 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000223 · wk-form4_1751505919.xml · derivative · entry 4 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,035 Underlying: Common Stock · 1,607 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 01:25 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 1,365 | $50.71 | $69,219.15 |
DisclosureSEC source: 0001576280-25-000223 · wk-form4_1751505919.xml · nonDerivative · entry 3 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,500 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 01:25 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,084 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000223 · wk-form4_1751505919.xml · nonDerivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,865 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 01:25 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,607 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000223 · wk-form4_1751505919.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,781 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2025 Filed Jun 17, 2025 00:04 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 637 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000189 · wk-form4_1750118657.xml · derivative · entry 3 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,550 Underlying: Common Stock · 637 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on June 15, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| June 15, 2025 Filed Jun 17, 2025 00:04 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 228 | $49.29 | $11,238.12 |
DisclosureSEC source: 0001576280-25-000189 · wk-form4_1750118657.xml · nonDerivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,174 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| June 15, 2025 Filed Jun 17, 2025 00:04 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 637 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000189 · wk-form4_1750118657.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,402 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 23:00 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 4,000 | $46.39 | $185,561.60 |
DisclosureSEC source: 0001576280-25-000165 · wk-form4_1749164329.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,765 Read SEC document |
| June 01, 2025 Filed Jun 2, 2025 22:04 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 710 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000159 · wk-form4_1748901862.xml · derivative · entry 3 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 711 Underlying: Common Stock · 710 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock unit award was granted on November 2, 2021, and vested as to 25% of the shares subject to such award on September 1, 2022. The remaining 75% of the shares subject to such award vests in equal installments on each quarterly anniversary of September 1, 2022 during the three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| June 01, 2025 Filed Jun 2, 2025 22:04 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 254 | $40.62 | $10,317.48 |
DisclosureSEC source: 0001576280-25-000159 · wk-form4_1748901862.xml · nonDerivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,765 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| June 01, 2025 Filed Jun 2, 2025 22:04 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 710 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000159 · wk-form4_1748901862.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,019 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2025 Filed Apr 2, 2025 21:36 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,084 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000118 · wk-form4_1743629812.xml · derivative · entry 5 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,503 Underlying: Common Stock · 1,084 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| April 01, 2025 Filed Apr 2, 2025 21:36 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,607 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000118 · wk-form4_1743629812.xml · derivative · entry 4 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,642 Underlying: Common Stock · 1,607 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vest in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| April 01, 2025 Filed Apr 2, 2025 21:36 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 961 | $42.47 | $40,813.67 |
DisclosureSEC source: 0001576280-25-000118 · wk-form4_1743629812.xml · nonDerivative · entry 3 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,450 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.